BackArcadia Biosciences Overview

Arcadia Biosciences Accounts Payable

Arcadia Biosciences's accounts payable is $0.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00
↓ 100.00% YoYΔ $-1.56M vs prior year quarter

Peer trimmed avg / median

Loading

Arcadia Biosciences Accounts Payable History

Loading

Arcadia Biosciences vs. peers: Accounts Payable Comparison

Loading

Arcadia Biosciences Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Arcadia Biosciences (RKDA) FAQ

As of the most recent data (June 2026), RKDA shows a accounts payable of $0. That compares with $1.6M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RKDA's accounts payable is now $0 (was $1.6M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Arcadia Biosciences is outperforming or lagging.

Tracking RKDA's accounts payable over time shows whether Arcadia Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $1.6M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Arcadia Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $0) with ownership activity and broader fundamentals.

Arcadia Biosciences's accounts payable is $0; compare it with other Materials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.